Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Staccato Alprazolam for Doxapram-Induced Panic Attacks
NCT00477451Phase 2Completed
- Sponsor
- Alexza Pharmaceuticals Inc
- Start
- May 2007
- Primary completion
- Apr 2008
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial of alprazolam in panic disorder (4 arms), sponsored by Alexza Pharmaceuticals Inc. Primary endpoints: Number of Participants With Doxapram-induced Panic Attack and Duration of the Doxapram-induced Panic Attack. Started May 2007; status: completed.
02
Drugs
alprazolam
03
Conditions
panic disorder
Beyond the preview
Go deeper on NCT00477451.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00477451.